| 产品名称： | Burkholderia cepacia (Palleroni and Holmes) Yabuuchi et al. |
|---|---|
| 商品货号： | TS208715 |
| Deposited As： | Pseudomonas sp. |
| Strain Designations： | 156-A FERM-P 1431 |
| Application： | Produces lipase Produces lipolytic substance GA-56 Produces extracellular lipase Opportunistic pathogen research Respiratory research |
| Isolation： | Soil, Aichi, Japan |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 820: Glutamate medium |
| Growth Conditions： | Temperature: 30°C
Atmosphere: Aerobic |
| Name of Depositor： | Amano Pharm. Co., Ltd. |
| U.S. Patent Number： | |
| References： | Kobayashi M. Lipid metabolism improving and anti-atheromatic agent. US Patent 3,875,007 dated Apr 1 1975 Kordel M, et al. Extracellular lipase of Pseudomonas sp. strain TS208715: purification, characterization, crystallization, and preliminary X-ray diffraction data. J. Bacteriol. 173: 4836-4841, 1991. PubMed: 1856176 |
| Cross References： | Nucleotide (GenBank) : AJ131766 Burkholderia cepacia hp gene. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Burkholderia cepacia (Palleroni and Holmes) Yabuuchi et al. |
|---|---|
| 商品货号： | TS208715 |
| Deposited As： | Pseudomonas sp. |
| Strain Designations： | 156-A FERM-P 1431 |
| Application： | Produces lipase Produces lipolytic substance GA-56 Produces extracellular lipase Opportunistic pathogen research Respiratory research |
| Isolation： | Soil, Aichi, Japan |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 820: Glutamate medium |
| Growth Conditions： | Temperature: 30°C
Atmosphere: Aerobic |
| Name of Depositor： | Amano Pharm. Co., Ltd. |
| U.S. Patent Number： | |
| References： | Kobayashi M. Lipid metabolism improving and anti-atheromatic agent. US Patent 3,875,007 dated Apr 1 1975 Kordel M, et al. Extracellular lipase of Pseudomonas sp. strain TS208715: purification, characterization, crystallization, and preliminary X-ray diffraction data. J. Bacteriol. 173: 4836-4841, 1991. PubMed: 1856176 |
| Cross References： | Nucleotide (GenBank) : AJ131766 Burkholderia cepacia hp gene. |
